Th1-Th2 balance

Management of immune-related cutaneous adverse events with dupilumab
Alyce Mei-Shiuan Kuo, Stephanie Gu, Joseph Stoll, Andrea P Moy, Stephen W Dusza, Allison Gordon, Elena C Haliasos, Yelena Janjigian, Lukas Kraehenbuehl, Elizabeth A Quigley, Paul Chapman, Mario E Lacouture, Alina Markova

Journal for ImmunoTherapy of Cancer Jun 2023, 11 (6) e007324; DOI: 10.1136/jitc-2023-007324
Local TLR4 stimulation augments in situ vaccination induced via local radiation and anti-CTLA-4 checkpoint blockade through induction of CD8 T-cell independent Th1 polarization
Justin C Jagodinsky, Amber M Bates, Paul A Clark, Raghava N Sriramaneni, Thomas C Havighurst, Ishan Chakravarty, Erin J Nystuen, KyungMann Kim, Paul M Sondel, Won Jong Jin, Zachary S Morris

Journal for ImmunoTherapy of Cancer Oct 2022, 10 (10) e005103; DOI: 10.1136/jitc-2022-005103
Enhanced efficacy of direct immunochemotherapy for hepatic cancer with image-guided intratumoral radiofrequency hyperthermia
Xuefeng Kan, Guanhui Zhou, Feng Zhang, Hongxiu Ji, David S Shin, Wayne Monsky, Chuansheng Zheng, Xiaoming Yang

Journal for ImmunoTherapy of Cancer Nov 2022, 10 (11) e005619; DOI: 10.1136/jitc-2022-005619
DPP inhibition alters the CXCR3 axis and enhances NK and CD8+ T cell infiltration to improve anti-PD1 efficacy in murine models of pancreatic ductal adenocarcinoma
Allison A Fitzgerald, Shangzi Wang, Veena Agarwal, Emily F Marcisak, Annie Zuo, Sandra A Jablonski, Melanie Loth, Elana J Fertig, John MacDougall, Eugene Zhukovsky, Shubhendu Trivedi, Dimple Bhatia, Vince O'Neill, Louis M Weiner

Journal for ImmunoTherapy of Cancer Nov 2021, 9 (11) e002837; DOI: 10.1136/jitc-2021-002837
Association between body mass index, dosing strategy, and efficacy of immune checkpoint inhibitors
Murtaza Ahmed, Mitchell S von Itzstein, Thomas Sheffield, Shaheen Khan, Farjana Fattah, Jason Y Park, Vinita Popat, Jessica M Saltarski, Yvonne Gloria-McCutchen, David Hsiehchen, Jared Ostmeyer, Saad A Khan, Nazima Sultana, Yang Xie, Quan-Zhen Li, Edward K Wakeland, David E Gerber

Journal for ImmunoTherapy of Cancer Jun 2021, 9 (6) e002349; DOI: 10.1136/jitc-2021-002349
Safety and clinical activity of intratumoral MEDI9197 alone and in combination with durvalumab and/or palliative radiation therapy in patients with advanced solid tumors
Lillian Siu, Joshua Brody, Shilpa Gupta, Aurélien Marabelle, Antonio Jimeno, Pamela Munster, Juneko Grilley-Olson, Alain H Rook, Antoine Hollebecque, Rebecca K S Wong, James W Welsh, Yuling Wu, Christopher Morehouse, Oday Hamid, Farzana Walcott, Zachary A Cooper, Rakesh Kumar, Charles Ferté, David S Hong

Journal for ImmunoTherapy of Cancer Oct 2020, 8 (2) e001095; DOI: 10.1136/jitc-2020-001095

Log in using your username and password

Main menu

Log in using your username and password

You are here

Th1-Th2 balance